Investigational Drug Information for NPC-06
✉ Email this page to a colleague
What is the drug development status for NPC-06?
NPC-06 is an investigational drug.
There have been 4 clinical trials for NPC-06.
The most recent clinical trial was a Phase 3 trial, which was initiated on August 15th 2022.
The most common disease conditions in clinical trials are Herpes Zoster, Acute Pain, and Neuralgia. The leading clinical trial sponsors are Nobelpharma and [disabled in preview].
Summary for NPC-06
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 830 |
| WIPO Patent Applications | 432 |
| Japanese Patent Applications | 50 |
| Clinical Trial Progress | Phase 3 (2022-08-15) |
| Vendors | 42 |
Recent Clinical Trials for NPC-06
| Title | Sponsor | Phase |
|---|---|---|
| A Phase 3 Study of NPC-06 in Patients With Pain Associated With Acute Herpes Zoster | Nobelpharma | Phase 3 |
| NPC-06 to Acute Pain in Herpes Zoster | Nobelpharma | Phase 2 |
| Phase II Clinical Trial of NPC-06 in Patients With Neuropathic Pain in Cancer | Nobelpharma | Phase 2 |
Clinical Trial Summary for NPC-06
Top disease conditions for NPC-06
Top clinical trial sponsors for NPC-06
US Patents for NPC-06
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
